Taylor, S.H. , Sutherland, G.R., Mackenzie, G.J., Staunton, H.P., and Donald, K.W.: The circulatory effects of intravenous phentolamine in man. Circulation. 31: 741. 1965.
2.
Taylor, S.H. , Mackenzie, G.J., George, M., and McDonald, A.: Effects of adrenergic blockade on the pulmonary circulation in man. Brit. Heart J..27: 627. 1965.
3.
Taylor, S.H. , Sutherland, G.R., Mackenzie, G.J., Staunton, H.P., and Donald, K.W.: The circulatory effects of phentolamine in man with particular respect to changes in forearm blood flow. Clin. Sc.,28: 265, 1965.
4.
Evans, G.L.Smulyan, H., and Eich, R.H.: Role of peripheral resistance in the control of cardiac output. Am. J. Cardiol.,20: 216, 1967.
5.
Goodman. L.S., and Gilman, A.The Pharmacological Basis of Therapeutics, Ed. 3, p. 557, Macmillan Co., New York, 1965.
6.
Gould, L., Zahir, M., and Ettinger, S.: Phentolamine and cardiovascular performance. Brit. Heart J.,31: 154, 1969.
7.
Weil, M.H., and Bradley, E.C.: Treatment of circulatory shock with adrenolytic (vasodilator) drug. J. Clin. Invest., 44: 1030, 1965.
8.
Vassale, M.: Role of catecholamine release in morphine hyperglycemia. Am. J. Physiol., 200: 530, 1961.
9.
Dairman, W., Gordon, R., Spector, S., Sjoerdsma, A., and Udenfriend, S.: Effect of alpha blockers on catecholamine biosynthesis. Fed. Proc., 27: 240, 1968.
